ROCHE HOLDING AG

ROG
Delayed Quote. Delayed  - 04/09 11:30:02 am
309.65CHF +0.81%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees : 101 465 people.
Sales per Business
20192020
CHF
(in Million)
%CHF
(in Million)
%
Pharmaceuticals 50,71482.5% 46,49179.7%
Diagnostics 13,03721.2% 13,85223.8%
Sales per region
20192020
CHF
(in Million)
%CHF
(in Million)
%
United States 31,16450.7% 28,63049.1%
Rest of Europe 9,67215.7% 9,78516.8%
Rest of Asia 8,71714.2% 8,62714.8%
Japan 4,6747.6% 4,2547.3%
Germany 3,0845% 3,3525.7%
Latin America 2,8584.6% 2,3934.1%
Africa, Australia and Oceania 1,3592.2% 1,3182.3%
Switzerland 1,2372% 1,1011.9%
Rest of North America 986.001.6% 883.001.5%
Managers
Name Title
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
André S. Hoffmann Vice Chairman
Paul Bulcke Non-Executive Director
Bernard J. Poussot Non-Executive Director
Richard P. Lifton Non-Executive Director
Claudia Süssmuth Dyckerhoff Director
Julie Brown Director
Shareholders
Name Equities %
Norges Bank Investment Management 19,938,101 2.84%
The Vanguard Group, Inc. 18,447,303 2.63%
Fidelity Management & Research Co. LLC 13,767,552 1.96%
UBS Asset Management Switzerland AG 11,390,134 1.62%
BlackRock Fund Advisors 10,874,680 1.55%
Roche Holding AG 9,436,750 1.34%
Credit Suisse Asset Management (Schweiz) AG 8,526,304 1.21%
Zürcher Kantonalbank (Investment Management) 7,345,807 1.05%
Massachusetts Financial Services Co. 7,330,438 1.04%
PRIMECAP Management Co. 5,560,379 0.79%
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : http://www.roche.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ROCHE HOLDING AG-4.36%288 043
JOHNSON & JOHNSON2.46%424 524
ROCHE HOLDING AG0.21%288 043
PFIZER, INC.-0.57%204 161
NOVARTIS AG-3.29%197 172
MERCK & CO., INC.-6.71%193 164
ABBVIE INC.0.36%189 789
ELI LILLY AND COMPANY9.27%167 700
NOVO NORDISK A/S2.68%161 501
AMGEN INC.8.28%143 346
BRISTOL-MYERS SQUIBB COMPANY0.94%139 866
ASTRAZENECA PLC-0.51%131 272
SANOFI8.08%126 247
GLAXOSMITHKLINE PLC-1.67%90 225
JIANGSU HENGRUI MEDICINE CO., LTD.-17.06%73 892
CHUGAI PHARMACEUTICAL CO., LTD.-20.81%65 300
ALLERGAN PLC0.97%63 659
BAYER AG10.77%62 273
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.13%53 479
DAIICHI SANKYO COMPANY, LIMITED-15.42%52 220
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.1.36%27 834
Brand Portfolio
ROCHE
ROCHE
FLATIRON HEALTH
FLATIRON HEALTH
FOUNDATION MEDICINE
FOUNDATION MEDICINE
GENENTECH
GENENTECH
PROMEDIOR
PROMEDIOR
STRATOS GENOMICS
STRATOS GENOMICS
TROPHOS
TROPHOS
VIEWICS
VIEWICS
» More brands of Roche Holding AG